Evaluating recovery and function after bone cancer surgery
Assessment of Healing and Function After Surgical Reconstruction for Neoplasms Involving Bone
This study looks at how well people recover and regain function after surgery for bone cancer, including the use of bone grafts or artificial devices, over three years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 4 Years and up |
| Sex | All |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 5 sites (Basking Ridge, New Jersey and 4 other locations) |
| Trial ID | NCT03442465 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the recovery of function in patients who have undergone reconstruction surgery for bone sarcomas, including the use of bone grafts or artificial devices. It will track the level of function and bone healing over a period of three years following surgery. Participants will be evaluated using various scoring systems and tests to measure their functional outcomes and the effectiveness of regenerative surgical techniques.
Who should consider this trial
Good fit: Ideal candidates include patients aged 4 and older with a history of primary bone neoplasms who are undergoing reconstructive surgery at Memorial Sloan Kettering Cancer Center.
Not a fit: Patients weighing less than 17 kilograms may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into improving recovery and functional outcomes for patients undergoing surgery for bone sarcomas.
How similar studies have performed: Other studies have shown promising results in assessing functional recovery after similar surgical interventions, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients undergoing reconstructive surgery for neoplasms involving bone on the orthopaedic surgery service at MSK * Current or prior history of primary neoplasms involving osseous structures, including all subtypes * Confirmation of diagnosis that has been performed by the MSK's Department of Pathology via direct review of tissue/slides * Patients must read and understand English * Age \>/=4 * Patients must read and understand English Exclusion Criteria: * Patients that weight \<17 kilograms
Where this trial is running
Basking Ridge, New Jersey and 4 other locations
- Memorial Sloan Kettering at Basking Ridge (Consent and Follow Up) — Basking Ridge, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Monmouth (Consent and Followup) — Middletown, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Westchester (Consent and Followup) — Harrison, New York, United States (Recruiting)
- Memorial Sloan Kettering Cancer Center — New York, New York, United States (Recruiting)
- Memorial Sloan Kettering at Nassau (Consent and Followup) — Uniondale, New York, United States (Recruiting)
Study contacts
- Principal investigator: Daniel Prince, MD — Memorial Sloan Kettering Cancer Center
- Study coordinator: Daniel Prince, MD, MPH
- Email: princed@mskcc.org
- Phone: 212-639-6488
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.